Noriko Tanaka
- Immunology and Allergy top 5%
-
- Cancer, Hypoxia, and Metabolism 3
-
- Cancer Treatment and Pharmacology 4
-
- Angiogenesis and VEGF in Cancer 5
- Glycosylation and Glycoproteins Research 2
-
- Pregnancy and preeclampsia studies 2
-
- Cancer Research and Treatments 2
-
- Microbial Natural Products and Biosynthesis 2
-
- Prostate Cancer Treatment and Research 2
- Co-authors
- Y OsadaMichio IwahanaAkiko TohgoHitoshi OgawaShizuo KadoyaMotomichi DoiRichard L. GalloShuji Nakamura
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Molecular Cancer Therapeutics (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Noriko Tanaka
20 papers receiving 534 citations
Peers
Comparison fields: 5 of 71
- Immunology and Allergy 107
- Cancer Research 132
- Hepatology 51
- Oncology 153
- Cell Biology 78
Countries citing papers authored by Noriko Tanaka
This map shows the geographic impact of Noriko Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Tanaka more than expected).
Fields of papers citing papers by Noriko Tanaka
This network shows the impact of papers produced by Noriko Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Tanaka. The network helps show where Noriko Tanaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noriko Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2019 | 2 | |
| 4 | 2006 | 20 | |
| 5 | 2004 | 2 | |
| 6 | 2004 | 1 | |
| 7 | 2003 | 17 | |
| 8 | 1998 | 10 | |
| 9 | 1996 | 12 | |
| 10 | 1993 | 19 | |
| 11 | 1992 | 61 | |
| 12 | Quantification of experimental pulmonary metastases by image analyzer. | 1992 | 1 |
| 13 | 1991 | 25 | |
| 14 | Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2. | 1991 | 133 |
| 15 | Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis. | 1990 | 57 |
| 16 | 1989 | 3 | |
| 17 | Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid. | 1989 | 50 |
| 18 | 1988 | 33 | |
| 19 | 1987 | 26 | |
| 20 | Platelet-aggregating activities of metastasizing tumor cells. II. Variety of the aggregation mechanisms. | 1984 | 22 |
About Noriko Tanaka
Noriko Tanaka is a scholar working on Biotechnology, Cancer Research and Obstetrics and Gynecology, having authored 22 papers that have together received 556 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Glycosylation and Glycoproteins Research (2 papers), Pregnancy and preeclampsia studies (2 papers), Cancer Research and Treatments (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Immunology and Allergy (107 citations), Cancer Research (132 citations) and Hepatology (51 citations). Noriko Tanaka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Y Osada, Michio Iwahana, Akiko Tohgo, Hitoshi Ogawa, Shizuo Kadoya, Motomichi Doi, Richard L. Gallo, Shuji Nakamura, Yumi Matsuzaki and Shinsaku Sakurada. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, JNCI Journal of the National Cancer Institute, Journal of Cellular Physiology and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.